1 results match your criteria: "Department of Allergy and Clinical Immunology Chiba University Hospital Chiba[Affiliation]"
Successful Treatment for Refractory Interstitial Lung Disease and Pneumomediastinum With Multidisciplinary Therapy Including Tofacitinib in a Patient With Anti-MDA5 Antibody-Positive Dermatomyositis.
J Clin Rheumatol
December 2021
Department of Allergy and Clinical Immunology Chiba University Hospital Chiba, Japan